- Home
- DOMH vs ADAG Comparison
DOMH vs ADAG Comparison
Compare DOMH & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOMH
- ADAG
- Stock Information
- Founded
- DOMH 1967
- ADAG 2011
- Country
- DOMH United States
- ADAG China
- Employees
- DOMH N/A
- ADAG N/A
- Industry
- DOMH Biotechnology: Pharmaceutical Preparations
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- DOMH Health Care
- ADAG Health Care
- Exchange
- DOMH Nasdaq
- ADAG Nasdaq
- Market Cap
- DOMH 94.0M
- ADAG 110.8M
- IPO Year
- DOMH N/A
- ADAG 2021
- Fundamental
- Price
- DOMH $5.97
- ADAG $2.04
- Analyst Decision
- DOMH
- ADAG Strong Buy
- Analyst Count
- DOMH 0
- ADAG 2
- Target Price
- DOMH N/A
- ADAG $7.00
- AVG Volume (30 Days)
- DOMH 261.5K
- ADAG 111.6K
- Earning Date
- DOMH 11-07-2025
- ADAG 08-12-2025
- Dividend Yield
- DOMH 8.98%
- ADAG N/A
- EPS Growth
- DOMH N/A
- ADAG N/A
- EPS
- DOMH N/A
- ADAG N/A
- Revenue
- DOMH $52,811,000.00
- ADAG $103,204.00
- Revenue This Year
- DOMH N/A
- ADAG $9,789.15
- Revenue Next Year
- DOMH N/A
- ADAG $29.92
- P/E Ratio
- DOMH N/A
- ADAG N/A
- Revenue Growth
- DOMH 455.38
- ADAG N/A
- 52 Week Low
- DOMH $0.83
- ADAG $1.33
- 52 Week High
- DOMH $13.58
- ADAG $3.16
- Technical
- Relative Strength Index (RSI)
- DOMH 48.51
- ADAG 45.09
- Support Level
- DOMH $5.90
- ADAG $2.24
- Resistance Level
- DOMH $7.18
- ADAG $2.49
- Average True Range (ATR)
- DOMH 0.45
- ADAG 0.22
- MACD
- DOMH -0.06
- ADAG -0.03
- Stochastic Oscillator
- DOMH 22.93
- ADAG 0.44
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.